159 related articles for article (PubMed ID: 33866110)
1. Impaired myeloid-derived suppressor cells are associated with recurrent implantation failure: A case-control study.
Jiang H; Zhu M; Guo P; Bi K; Lu Z; Li C; Zhai M; Wang K; Cao Y
J Reprod Immunol; 2021 Jun; 145():103316. PubMed ID: 33866110
[TBL] [Abstract][Full Text] [Related]
2. Sildenafil might impair maternal-fetal immunotolerance by suppressing myeloid-derived suppressor cells in mice.
Jiang HH; Wang KX; Bi KH; Lu ZM; Zhang JQ; Cheng HR; Zhang MY; Su JJ; Cao YX
J Reprod Immunol; 2020 Nov; 142():103175. PubMed ID: 32682164
[TBL] [Abstract][Full Text] [Related]
3. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
4. Decidua-derived granulocyte macrophage colony-stimulating factor induces polymorphonuclear myeloid-derived suppressor cells from circulating CD15+ neutrophils.
Li C; Chen C; Kang X; Zhang X; Sun S; Guo F; Wang Q; Kou X; Bai W; Zhao A
Hum Reprod; 2020 Dec; 35(12):2677-2691. PubMed ID: 33067638
[TBL] [Abstract][Full Text] [Related]
5. Myeloid-derived suppressor cells as a potential biomarker for recurrent pregnancy loss and recurrent implantation failure: Increased levels of MDSCs in recurrent reproductive failure.
Marin NS; Fuente-Muñoz E; Gil-Laborda R; Villegas Á; Alonso-Arenilla B; Cristóbal I; Pilar-Suárez L; Jiménez-Huete A; Calvo M; Sarria B; Mansilla-Ruiz M; Ochoa J; Fernández-Arquero M; Sánchez-Ramón S
Am J Reprod Immunol; 2023 Nov; 90(5):e13783. PubMed ID: 37881123
[TBL] [Abstract][Full Text] [Related]
6. Frontline Science: Myeloid-derived suppressor cells (MDSCs) facilitate maternal-fetal tolerance in mice.
Ostrand-Rosenberg S; Sinha P; Figley C; Long R; Park D; Carter D; Clements VK
J Leukoc Biol; 2017 May; 101(5):1091-1101. PubMed ID: 28007981
[TBL] [Abstract][Full Text] [Related]
7. Expansion of PMN-myeloid derived suppressor cells and their clinical relevance in patients with oral squamous cell carcinoma.
Zhong LM; Liu ZG; Zhou X; Song SH; Weng GY; Wen Y; Liu FB; Cao DL; Liu YF
Oral Oncol; 2019 Aug; 95():157-163. PubMed ID: 31345384
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of pregnancy-associated granulocytic myeloid-derived suppressor cell expansion and arginase-1 production in preeclampsia.
Wang Y; Liu Y; Shu C; Wan J; Shan Y; Zhi X; Sun L; Yi H; Yang YG; He J
J Reprod Immunol; 2018 Jun; 127():48-54. PubMed ID: 29763854
[TBL] [Abstract][Full Text] [Related]
9. Myeloid-derived suppressor cells impede T cell functionality and promote Th17 differentiation in oral squamous cell carcinoma.
Dar AA; Patil RS; Pradhan TN; Chaukar DA; D'Cruz AK; Chiplunkar SV
Cancer Immunol Immunother; 2020 Jun; 69(6):1071-1086. PubMed ID: 32103293
[TBL] [Abstract][Full Text] [Related]
10. Continuous activation of polymorphonuclear myeloid-derived suppressor cells during pregnancy is critical for fetal development.
Shi M; Chen Z; Chen M; Liu J; Li J; Xing Z; Zhang X; Lv S; Li X; Zuo S; Feng S; Lin Y; Xiao G; Wang L; He Y
Cell Mol Immunol; 2021 Jul; 18(7):1692-1707. PubMed ID: 34099889
[TBL] [Abstract][Full Text] [Related]
11. Involvement of impaired CD8
Zhu M; Xu Y; Li C; Lu Z; Bi K; Wang K; Guo P; Jiang H; Cao Y
Reprod Biol Endocrinol; 2021 Nov; 19(1):175. PubMed ID: 34847942
[TBL] [Abstract][Full Text] [Related]
12. Myeloid-derived suppressor cells depletion may cause pregnancy loss via upregulating the cytotoxicity of decidual natural killer cells.
Ren J; Zeng W; Tian F; Zhang S; Wu F; Qin X; Zhang Y; Lin Y
Am J Reprod Immunol; 2019 Apr; 81(4):e13099. PubMed ID: 30737988
[TBL] [Abstract][Full Text] [Related]
13. Prednisone improves pregnancy outcome in repeated implantation failure by enhance regulatory T cells bias.
Huang Q; Wu H; Li M; Yang Y; Fu X
J Reprod Immunol; 2021 Feb; 143():103245. PubMed ID: 33161280
[TBL] [Abstract][Full Text] [Related]
14. Increase in polymorphonuclear myeloid-derived suppressor cells and regulatory T-cells in children with B-cell acute lymphoblastic leukemia.
Zahran AM; Shibl A; Rayan A; Mohamed MAEH; Osman AMM; Saad K; Mahmoud KH; Ghandour AMA; Elsayh KI; El-Badawy O
Sci Rep; 2021 Jul; 11(1):15039. PubMed ID: 34294814
[TBL] [Abstract][Full Text] [Related]
15. Myeloid derived suppressor cells in peripheral blood can be a prognostic factor in canine transitional cell carcinoma.
Yokota S; Yonezawa T; Momoi Y; Maeda S
Vet Immunol Immunopathol; 2024 Mar; 269():110716. PubMed ID: 38308864
[TBL] [Abstract][Full Text] [Related]
16. Myeloid-derived suppressor cells expansion is closely associated with disease severity and progression in HBV-related acute-on-chronic liver failure.
Zeng Y; Li Y; Xu Z; Gan W; Lu L; Huang X; Lin C
J Med Virol; 2019 Aug; 91(8):1510-1518. PubMed ID: 30905084
[TBL] [Abstract][Full Text] [Related]
17. Myeloid-Derived Suppressor Cells Promote the Progression of Primary Membranous Nephropathy by Enhancing Th17 Response.
Li H; Wu H; Guo Q; Yu H; Xu Y; Yu J; Wang Z; Yi H
Front Immunol; 2020; 11():1777. PubMed ID: 32973748
[TBL] [Abstract][Full Text] [Related]
18. Estradiol correlates with the accumulation of Monocytic Myeloid-Derived Suppressor Cells in Pre-term birth: A possible explanation of immune suppression in pre-term babies.
Budhwar S; Verma R; Verma P; Bala R; Rai S; Singh K
J Reprod Immunol; 2021 Sep; 147():103350. PubMed ID: 34293589
[TBL] [Abstract][Full Text] [Related]
19. Circulating and Tumor Myeloid-derived Suppressor Cells in Resectable Non-Small Cell Lung Cancer.
Yamauchi Y; Safi S; Blattner C; Rathinasamy A; Umansky L; Juenger S; Warth A; Eichhorn M; Muley T; Herth FJF; Dienemann H; Platten M; Beckhove P; Utikal J; Hoffmann H; Umansky V
Am J Respir Crit Care Med; 2018 Sep; 198(6):777-787. PubMed ID: 29617574
[TBL] [Abstract][Full Text] [Related]
20. Circulating Myeloid-Derived Suppressor Cell Subsets in Patients with Colorectal Cancer - Exploratory Analysis of Their Biomarker Potential.
Fědorová L; Pilátová K; Selingerová I; Bencsiková B; Budinská E; Zwinsová B; Brychtová V; Langrová M; Šefr R; Valík D; Zdražilová Dubská L
Klin Onkol; 2018; 31(Suppl 2):88-92. PubMed ID: 31023030
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
